White label – Pompe disease - ClinicalTrials.eu

Study on the Effects of SAR443820 and Gadobutrol in Patients with Multiple Sclerosis

Not recruiting

2 1 1
Investigated Diseases:
- Multiple sclerosis
Investigated Drugs:
- Oditrasertib
- Gadobutrol
+1
Study of intravenous zanamivir safety and effectiveness in infants under 6 months of age with complicated influenza infection

Not recruiting

2 1 1 1
Investigated Diseases:
- Influenza
Investigated Drugs:
- Zanamivir
Study on the Safety, Effectiveness, and Blood Movement of Bimekizumab in Adolescents with Moderate to Severe Plaque Psoriasis

Not recruiting

2 1 1
Investigated Diseases:
- Psoriasis
Investigated Drugs:
- Bimekizumab
Study on the Long-Term Safety and Effectiveness of Losmapimod for Patients with Facioscapulohumeral Muscular Dystrophy (FSHD)

Not recruiting

2 1 1
Investigated Diseases:
- Facioscapulohumeral muscular dystrophy
Investigated Drugs:
- Losmapimod
Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced or Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations

Not recruiting

3 1 1 1
Investigated Drugs:
- Datopotamab Deruxtecan
- Pembrolizumab
+6
Study on the Safety and Effectiveness of Cenobamate for Children with Focal Seizures

Not recruiting

3 1 1
Investigated Diseases:
- Partial seizures
Investigated Drugs:
- Cenobamate
Remote Study on Empagliflozin and Finerenone for Reducing Kidney Issues in Type 2 Diabetes Patients

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
- Finerenone
- Empagliflozin
Study on AVP-786 for Treating Agitation in Alzheimer’s Dementia Patients

Not recruiting

3 1
Investigated Diseases:
- Dementia Alzheimer’s type
Investigated Drugs:
- Deudextromethorphan Hydrobromide
- Quinidine Sulfate
+2
Study of BT5528 alone and with nivolumab in patients with advanced solid tumors that have EphA2 protein expression

Not recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm malignant
Investigated Drugs:
- Monomethyl Auristatin E Linked To A Sarcosine Decamer With A Beta-Alanine N-Terminus And Bcy9594 Via A Cleavable Linker
- Nivolumab
Study of Mosunetuzumab and Drug Combination for Untreated Patients with Richter’s Syndrome

Not recruiting

2 1 1 1
Investigated Diseases:
- Richter’s syndrome
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies